A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.

Hengyu ChenXianxiong MaMing YangMengyi WangLei LiTao Huang

Published in: Cancer medicine (2020)

The results suggested that the 6-DNA methylation signature is the independent prognostic marker for RFS and functioned as a significant tool for guiding the clinical treatment of TPC patients.

Keyphrases

free survival
dna methylation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
genome wide
lymph node metastasis